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Department of Cell and Molecular Biology, Lund University, Lund, SwedenConnective tissues—an introduction
The connective tissues are crucial for multicellular
organisms, playing many diverse roles both structurally and
mechanically as well as providing a protective function.
They make up the frame of the mammalian body and add
strength and elasticity, while their protective function is
important both on the outside of the body and inside, where
they surround and support the inner organs. Connective
tissues consist mainly of extracellular matrix (ECM) sur-
rounding a sparse population of cells. The framework of the
ECM consists of insoluble fibrils primarily of collagen. The
structure of the fibrils varies depending on the demands
the tissue has to meet. An important determinant is the
proportion of different collagen types. However, the shape,
organization and mechanical properties of the fibrils also
depend on the presence of other ECM glycoproteins and
proteoglycans.
Cartilage represents a specialized connective tissue that
is a major target in joint diseases affecting more than 10%
of the population. To understand the biology and the
pathology of events in the articular cartilage in repair and in
disease leading to destruction, it is of essence to discern
key constituents in the matrix and their functions. Most of
the macromolecules in the cartilage are not unique to this
tissue and are present in other tissues where they have
similar functions. Thus the more general discussion on the
constituents of the fibrillar networks very much applies to
cartilage, where it contains a mixture of molecules specific
to cartilage and others present in many tissues.
The major constituents of cartilage are collagen
type II, hyaluronan and the cartilage-specific proteoglycan
aggrecan. Aggrecan binds to hyaluronan to form large
aggregates, which due to their extensive charge, hydrate
the tissue resulting in a high osmotic swelling pressure.
Collagen type II is by far the major constituent of a network
of thin fibrils entrapping and interacting with the aggrecan/
hyaluronan aggregates thus endowing the cartilage with
its ability to resist compressive load and providing both
mechanical stiffness and resilience.
The bulk collagen in banded fibrils in almost all tissues is
type I collagen. A notable exception from this rule is hyaline
cartilage, where type II collagen replaces type I collagen.
However, the mode of aggregation of these collagens is to
a significant extent determined by other matrix macro-
molecules with which they are alloyed into D-periodically
banded fibrils. In this way, structural and functional tissueS23diversity of collagen fibrils is accomplished. The solid
strength of bone, another important structural entity of the
joint, is achieved by mineralization of the extracellular
matrix. Mineral crystals of hydroxyapatite comprise about
two-thirds of the dry weight of bone and are formed in a
lattice of collagen type I fibrils.Collagens
Collagens are the most abundant proteins in the body,
providing the necessary mechanical stability and protection
from external physical stress. Defects in collagen or colla-
gen metabolism have been connected to genetic defects
and diseases such as osteogenesis imperfecta, chondro-
dysplasia, osteoarthritis, rheumatoid arthritis, osteoporosis,
and fibrotic diseases1,2. Distinct collagen families differ in
their ability to form fibrils as discussed below.FIBRIL-FORMING COLLAGENS
Fibril-forming collagens make up 90% of the total colla-
gens and represent a mjaor molecular constituents of fibrils
with a specific banded pattern. The five members of this
subfamily, collagen types I, II, III, V and XI, contain long
triple helical domains with about 1000 amino acid residues
per chain. Collagen type I is by far the most abundant
collagen and found in skin, bone, tendon and many other
tissues. Collagen type II is the major collagen of cartilage
and the vitreous. Collagen type III is associated with
collagen type I in skin fibrils3. Collagen types V and XI are
considered as minor collagens and are associated with
type I and type II collagen, respectively.
The fibril-forming collagens are synthesized as larger
precursors known as procollagen and contain both amino-
and carboxy-terminal propeptides (N- and C-propeptides).
The propeptides are usually removed after secretion of the
molecule, leaving a short, non-triple helical telopeptide at
each end of the molecule. In collagen types III, V and XI the
N-propeptides or parts thereof can be retained in the
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Collagen types IX, XII and XIV do not form fibrils by
themselves, but are essential constituents co-aggregating
with fibril forming collagens and modulate outside inter-
actions of fibrils by domains projecting from their surfaces.
They have short triple helical domains interrupted by short
non-collagenous sequences. These characteristics gave
S24 L. Svensson et al.: Collagen binding proteinsthe subfamily its name; FACIT collagens, for fibril-
associated collagens with interrupted triple helices7. Colla-
gen type IX is the most extensively studied collagen in this
group. It is commonly found covalently linked to collagen
type II in fibrils and often occurs in a proteoglycan form with
a single glycosaminoglycan chain8,9. By rotary shadowing
the amino-terminal (N-terminal) triple helical NC3- and the
globular, cationic NC4-domains are seen protruding from
the fibril surface. Collagen types XII and XIV show some
structural similarities to collagen type IX10,11. Both colla-
gens occur in different splice variants of which some may
be substituted with glycosaminoglycan chains12. They are
localized to collagen fibrils in skin and cartilage.
Collagen type X forms hexagonal lattices and is found
primarily in hypertrophic cartilage13.
Collagen type VI is present in many tissues such as skin,
cornea and cartilage14,15. Extensive disulphide cross-
linking leads to the assembly of characteristically long, thin,
beaded filamentous structures. Collagen type VI binds
to many cell types and also interacts with other matrix
proteins, such as hyaluronan, decorin and biglycan16–18.Leucine-rich repeat glycoproteins/proteoglycans
Proteins containing leucine-rich repeats (LRRs) are
found in mammals, birds, plants, insects, bacteria and
yeast and are implicated in a variety of protein–protein
interactions19. These interactions are involved in such
diverse functions as signal transduction and assembly of
the ECM. Each LRR consists of 20–29 amino acids con-
taining leucine residues in conserved positions. The super-
family of LRR proteins can be divided into subfamilies
based on the lengths and consensus sequences of the
repeated motif. The members of the ECM leucine-rich
repeat (ECM LRR) glycoprotein/proteoglycan subfamily
have core proteins of about 40 kDa and characteristic
cysteine clusters flanking the LRR domain.Fig. 1. A. Schematic illustration of biglycan, decorin, fibromodulin
and lumican. B. Dendrogram illustrating the evolutionary relation-
ship between the ten known members of the ECM LRR protein
family.STRUCTURE OF ECM LRR PROTEINS
The family of ECM LRR proteins comprises at least ten
members, all of which share the common feature of a
prominent central domain consisting of LRRs, where each
LRR consists of about 24 amino acids (Fig. 1). The N- and
C-terminal regions are less conserved but are recognized
by specific patterns of cysteine residues involved in
intrachain disulphide bonds20. This family of ECM LRR
proteins can be further divided into four subfamilies based
on similarities in gene organization and amino acid
sequences.
Decorin and biglycan belong to one subfamily showing
57% protein sequence identity21,22. Both have N-terminal
domains substituted with one (decorin) or two (biglycan)
chondroitin/dermatan-sulphate chains. Decorin and bi-
glycan are ubiquitous components found in a wide variety
of tissues such as skin, bone, tendon, aorta and
cartilage22,23.
Another subfamily includes fibromodulin, lumican,
keratocan, PRELP and osteoadherin24–28. In this subfamily
fibromodulin and lumican are closely related, showing 48%
amino acid sequence identity. They are widespread and
have similar expression patterns in tissues like cartilage,
heart, placenta, skeletal muscle, kidney and pancreas29.
Fibromodulin contains a cluster of sulphated tyrosine
residues in the N-terminal domain30. Similarly, theN-terminal domain of lumican contains tyrosine residues,
which are also likely to be sulphated25. Both fibromodulin
and lumican contain asparagine (Asn) linked carbo-
hydrates in the central LRR domain. In fibromodulin syn-
thesized by chondrocytes, tendon and scleral fibroblasts,
Asn residues in the LRR region can serve as acceptor sites
for keratan sulphate30. Lumican exists as a keratan sul-
phate proteoglycan primarily in the cornea, while being a
classical glycoprotein in tissues such as skin, tendon and
cartilage29.
Keratocan and PRELP show 53% sequence identity.
Keratocan is abundant in cornea and sclera, and found in
lesser amounts in tissues such as skin, cartilage and
ligaments26. Keratocan has at least one potential site for
tyrosine sulphation in the N-terminal domain. Like lumican,
corneal keratocan is a keratan sulphate proteoglycan.
PRELP (proline arginine-rich end leucine-rich repeat pro-
tein) has a unique N-terminal domain with a high content of
basic amino acid residues27. PRELP was originally purified
from cartilage, but is also present in other connective
tissues such as skin, tendon, cornea and sclera31. Osteo-
adherin is a keratan sulphate proteoglycan in bovine bone
with tyrosine sulphate residues and shows 42% amino acid
sequence identity to keratocan32. This proteoglycan is
found in bone only and has been shown to bind to cells28.
Chondroadherin has a very short amino-terminal region
and an extra disulphide bond in the C-terminal domain33.
Chondroadherin is a cell-binding protein prominently
expressed in cartilage34.
The LRR motif is known to be involved in protein–
protein interactions, e.g. between ribonuclease and the
Osteoarthritis and Cartilage Vol. 9 Suppl. A S25ribonuclease inhibitor (RNase inhibitor). The RNase inhibi-
tor contains 15 LRRs, which make up 90% of the molecule
and possesses only short N- and C-terminal domains35.
The RNase inhibitor forms a horseshoe-shaped coil of
alternating -helices and -sheets. The -helices are
located on the outer boundary of the arch and the parallel
-sheets are situated on the inner concave surface. This
structural motif appears to be specific for LRR-proteins.
The ECM LRR proteins have fewer and shorter LRRs and
in addition have more prominent domains flanking the
internal repeated motif compared to the RNase inhibitor.
Rotary shadowing and electron microscopy of decorin
and fibromodulin/lumican indicate that these proteins
also have a similar horseshoe-shaped three-dimensional
structure36. Computer modelling of decorin, based on
the ribonuclease inhibitor structure, suggests a similar
arch-shaped molecule37.ECM LRR PROTEIN INTERACTIONS
With the exception of osteoadherin, it appears that most
of 10-11 LRRP repeats proteins are present in cartilage,
albeit at different concentrations. Decorin, fibromodulin and
PRELP appears most prominent followed by chondro-
adherin, that has a much more restricted distribution than
the others to primarily cartilage.
Binding to collagen is a prominent feature of some ECM
LRR proteins. Decorin is the most extensively studied
member of the family and binds to collagen types I, II, III, V,
VI, XII and XIV18,38–41. Binding of decorin to collagen type
I was shown to affect fibrillogenesis in vitro, creating thinner
than normal fibrils42. The interaction of decorin with colla-
gen depends on the core protein since the removal of the
glycosaminoglycan chain does not alter the binding prop-
erties. Furthermore, isolated glycosaminoglycan chains do
not interfere with proteoglycan binding. Subsequently, fibro-
modulin43 and lumican44 were also shown to possess
collagen-binding properties in vitro. Decorin and fibromodu-
lin seem to bind to separate sites on the collagen fibril,
since they do not compete with each other for binding
to collagen type I45. Biglycan, which is closely related to
decorin, does not show any significant binding in vitro to
fibres of collagen type I46 and does not co-localize with
collagen type I-containing fibrils in tissues47. Biglycan, as
well as decorin and fibromodulin have been implied to bind
to collagen type VI18.
The binding site for collagen type I in the decorin core
protein has been localized to repeats 4 to 5 in the LRR
domain46,48, with a glutamate residue within this region
being suggested to play a critical role for the interaction
with the collagen49. The binding site for fibromodulin to
collagen appears to reside in the C-terminal part of the
proteoglycan50.
The ECM LRR proteins are not only involved in collagen
fibrillogenesis, but may also have functions in regulation of
cell growth, migration and adhesion. Decorin binds to
fibronectin51, thrombospondin52, complement component
C1q53, membrane receptors prior to endocytosis54 and
epidermal growth factor receptor (EGFR)55. Decorin,
biglycan and fibromodulin also bind transforming growth
factor- (TGF-)56,57. The binding of decorin to EGFR and
TGF- is suggested to be involved in the regulation of cell
growth. Decorin binding to EGFR is associated with cell-
cycle arrest and causes suppression of the growth of
various tumor cell lines58. Fibrotic diseases are character-
ized by accumulation of collagen and involve increasedTGF- production. Decorin has been shown to neutralize
the effect of TGF- in cell cultures and may prevent fibrotic
disease when used in the treatment of rats with experimen-
tal glomerulonephritis56,59,60. Cell binding has also been
shown for chondroadherin and osteoadherin, which bind to
cells via integrins 21 and v3, respectively28,34.Assembly and modifications of collagen
Collagen fibrillogenesis is a multistep process involving
both intracellular and extracellular assembly reactions2,61.
The various steps are regulated by a number of factors,
largely not well characterized, and many of the details
remain to be elucidated.
During the fibril assembly process there are numerous
stages where fibril characteristics, such as fibril diameter,
may be regulated. Differences in glycosylation and pro-
peptide processing have been suggested to be involved
in the regulation of fibril diameter. Other possible mech-
anisms for regulation are the association of different colla-
gen types into heterotypic fibrils and interactions with
non-collagenous proteins, such as proteoglycans. Thus,
binding of non-collagenous proteins to collagen has been
shown to influence the fibrillogenesis. Most extensively
studied are the interactions between collagen type I and
members of the ECM LRR glycoprotein/proteoglycan fam-
ily. Early studies showed that the binding of decorin,
fibromodulin and lumican to collagen type I was able to
affect collagen fibrillogenesis in vitro38,42–44. The situation
in vivo is more complex with an interplay between a number
of factors enhancing and inhibiting the process of fibril
formation.
The role of these collagen-binding ECM LRR
glycoproteins/proteoglycans in the assembly of the extra-
cellular matrix has been further evaluated in vivo by the use
of transgenic mice, where the expression of one specific
protein is deleted by gene targeting techniques. The
phenotypes of the mice lacking one of these glycoproteins/
proteoglycans are relatively mild. The mice are born alive,
they are fertile and have a normal lifespan, however, they
show defects involving connective tissues. The decorin-null
mice have fragile skin with reduced tensile strength62.
Collagen fibrils from both skin and tendon are abnormal in
size and shape. These results suggest that the assembly of
the collagen matrix is disturbed, leading to tissues lacking
normal properties. Lumican-null mice have fragile skin with
reduced tensile strength and show corneal opacity63. Col-
lagen fibrils from both skin and cornea are abnormal in a
similar way to the decorin-null mice. In tendon, mice lacking
fibromodulin also show a disorganized collagen matrix, with
abnormalities in size and shape of their collagen fibrils64.
The abnormal collagen fibrils from these different mouse
strains resemble the fibrils from patients with certain forms
of Ehlers–Danlos Syndrome (EDS). The cause of the
defect is known for some of the types of EDS, where
mutations in the genes for the collagen -chains or in
proteins involved in posttranslational modifications or
processing of the collagen have been described. The
results from the ECM LRR glycoprotein/proteoglycan-null
mice may give an indication as to the possible involvement
of these proteins in EDS or related disorders affecting
collagen matrices.
The LRRP-proteins appear to also have roles in the
function of the assembled fibrils. Thus, both decorin and
fibromodulin have been identified bound to collagen fibres
S26 L. Svensson et al.: Collagen binding proteinsin the tissue, localized at the gap region65. Furthermore, a
population comprising a few percent of banded fibres with
collagen II has been possible to extract from young
cartilage. A proportion of these fibres contained bound
decorin66. Interestingly another subclass of the minor
population of the total tissue collagen II-containing fibres
that could be extracted contained collagen IX. Whether this
differential distribution is unique for the small extracted
pool or relevant to the total pool in the tissue remains to
be verified. The result, however, clearly demonstrate
heterogeneity among the banded fibres.
Other proteins may also have a role in collagen
assembly. In tendon, mice lacking thrombospondin 2
(TSP2) show abnormal collagen type I fibrils which
resemble the fibrils from the decorin-null mice. TSP2 does
not bind to cells, but affects the adhesion properties of
cells. This defect in adhesiveness may cause abnormal
collagen fibril formation67.Acknowledgments
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